Publication | Closed Access

Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort

Patients Secondary ResectedSurgical OncologyPancreatic CancerGastrointestinal OncologyMedicineSurgical PathologyPathologyPancreatic SurgerySurgeryCancer TreatmentOncologyPathologic Major ResponseCancer ResearchMulticentric Cohort